Article Text

Download PDFPDF
HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis

Statistics from


  • The first two authors contributed equally.

  • Funding This study was supported by a grant from CGM, RIKEN and a grant for Research on Intractable Diseases and Research on Human Genome Tailor-Made from the Ministry of Health, Labour and Welfare of Japan.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Approved by the Ethical Committee of the BioBank Japan Project.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.